Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Natalizumab treatment reduces endothelial activity in MS patients.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Multiple Sclerosis in Children.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
Is the treatment of multiple sclerosis headed in the wrong direction?
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Very early MS -- insights from MRI.
Multiple sclerosis: summary of NICE guidance.
Pages
« first
‹ previous
…
191
192
193
194
195
196
197
198
199
…
next ›
last »